<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="abstract"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Intensive Care Med Exp</journal-id><journal-id journal-id-type="iso-abbrev">Intensive Care Med Exp</journal-id><journal-title-group><journal-title>Intensive Care Medicine Experimental</journal-title></journal-title-group><issn pub-type="epub">2197-425X</issn><publisher><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4796638</article-id><article-id pub-id-type="publisher-id">275</article-id><article-id pub-id-type="doi">10.1186/2197-425X-3-S1-A129</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Comparison of multidrug-resistant acinetobacter and non-acinetobacter infections in terms of outcome in critically ill patients</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Madaan</surname><given-names>A</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Singh</surname><given-names>V</given-names></name><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Singh</surname><given-names>VJ</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><label/>Patel Super Speciality Hospital, Critical Care Medicine, Jalandhar, India </aff><aff id="Aff2"><label/>Sir Ganga Ram Hospital, Critical Care Medicine, New Delhi, India </aff></contrib-group><pub-date pub-type="epub"><day>1</day><month>10</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>1</day><month>10</month><year>2015</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2015</year></pub-date><volume>3</volume><issue>Suppl 1</issue><issue-sponsor>The publication charges for this supplement were funded by Intensive Care Medicine Experimental.</issue-sponsor><elocation-id>A129</elocation-id><permissions><copyright-statement>&#x000a9; Madaan et al.; 2015</copyright-statement><license license-type="open-access"><license-p>This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><conference><conf-name>ESICM LIVES 2015</conf-name><conf-loc>Berlin, Germany</conf-loc><conf-date>3-7 October 2015</conf-date><string-conf><uri>http://www.esicm.org/</uri></string-conf></conference><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2015</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p>Acinetobacter infections have increased and gained attention because of the organism's prolonged environmental survival and propensity to develop antimicrobial drug resistance [<xref ref-type="bibr" rid="CR1">1</xref>],[<xref ref-type="bibr" rid="CR2">2</xref>]. We performed a retrospective, matched cohort investigation at a tertiary care hospital in a tier II city hospital of India to examine morbidity and mortality outcome of patients with multidrug-resistant (MDR) Acinetobacter (AB) infection compared with patients with MDR non-Acinetobacter (non-AB) infections.</p></sec><sec id="Sec2"><title>Objectives</title><p>To study the outcome difference in terms of morbidity and mortality in critically ill patients with MDR infections.</p></sec><sec id="Sec3"><title>Methods</title><p>Patient records from the last 3 years from 2011 through 2013 were studied (<italic>n</italic> = 104) to examine outcomes of hospitalized patient in terms of number of organ dysfunctions, ICU length of stay, hospital length of stay and mortality in patients infected with MDR AB infection compared with the patients with MDR non-AB infection.</p></sec><sec id="Sec4"><title>Results</title><p>MDR AB-infected patients (<italic>n</italic> = 45, 43%) had greater number oforgan dysfunctions, and higher mean lengths of hospital stay (8.4 days vs. 6.1 days) and ICU stay (5.3 days vs. 0.8 days) after the index day than MDR non-AB infection (<italic>n</italic> = 59, 57%) (Table <xref rid="Tab1" ref-type="table">1</xref>). In-hospital mortality rates for patients with MDR AB infections (42%) were higher than for MDR non-AB infection (10%). <italic>F</italic> critical = 3.934253.<table-wrap id="Tab1"><caption><p>Table 1</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Outcome evaluated</th><th align="left">MDR AB</th><th align="left">MDR non-AB</th><th align="left">p value</th><th align="left">f value</th></tr></thead><tbody><tr><td align="left">Mean length of stay after index day</td><td align="left">8.488889</td><td align="left">6.101695</td><td align="left">0.029299</td><td align="left">4.886684</td></tr><tr><td align="left">Mean ICU stay after index day</td><td align="left">5.311111</td><td align="left">0.864407</td><td align="left">1.73*10<sup>-11</sup></td><td align="left">57.30083</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec5"><title>Conclusions</title><p>We demonstrated in patients infected with MDR strains of any organism that patients infected with Acinetobacter have greater number of organ dysfunction, longer lengths of stay in both the hospital and the ICU as well as increased mortality than patients infected with non-Acinetobacter infection when we controlled for severity of illness.</p></sec></body><back><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahgoub</surname><given-names>S</given-names></name><etal/></person-group><source>Infection Control Hosp Epidemiol</source><year>2002</year><volume>23</volume><fpage>477</fpage><lpage>479</lpage><pub-id pub-id-type="doi">10.1086/502091</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsueh</surname><given-names>PR</given-names></name><etal/></person-group><source>Emerg Infect Dis</source><year>2002</year><volume>8</volume><fpage>827</fpage><lpage>832</lpage><pub-id pub-id-type="doi">10.3201/eid0805.020014</pub-id><pub-id pub-id-type="pmid">12141969</pub-id></element-citation></ref></ref-list></back></article>